en

PRODUCT DETAIL

Leqvio 284 mg injekčný roztok v naplnenej injekčnej striekačke

Code 0816E
MA number EU/1/20/1494/002
Product Form: sol inj 1x1,5 ml/284 mg (striek.inj.skl.+chránič ihly)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10A Lipid modifying agents, plain
C10AX Other lipid modifying agents
C10AX16 Inclisiran
Shelf life: 36
Container: injection syringe
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 09.12.2020
Validity: 09.12.2025
SmPC + PL: European Medicines Agency's database
Dokument: DHPC_Leqvio_Pokyny na použitie pred podaním injekcie_15-12-2023.pdf  
Safety feature Yes
Data update: 17.05.2022
eu-flag.png sk-flag.png